skip to Main Content

Bone and the perimenopause

Loss of ovarian function has a profound impact on female skeletal health. Bone mineral density findings from the Study of Women’s Health Across the Nation demonstrate an accelerated rate of bone loss during the menopausal transition. The greatest reduction occurs in the year before the final menstrual period and the first 2 years thereafter. Clinical management includes maintenance of adequate dietary calcium and vitamin D intake, attention to modifiable risk factors, and osteoporosis screening. Indications, benefits, and risks of pharmacologic osteoporosis therapy should be assessed individually; there are currently no established guidelines addressing the treatment and prevention of osteoporosis in perimenopausal women.

Authors: Lo JC; Burnett-Bowie SA; Finkelstein JS

Obstet Gynecol Clin North Am. 2011 Sep;38(3):503-17.

PubMed abstract

Explore all studies and publications

Back To Top